Cancer immunologist with focus on the response to checkpoint inhibition and resistance mechanisms involving induction of immune suppression. Special interest in the combination of radiation therapy and immunotherapy.

Current projects include characterization of systemic immune responses to checkpoint inhibition in patient samples from clinical trials exploring combination therapy (NIPU, DART, COM-IT-2).

Key competences: spectral flow cytometry analysis of human and mouse samples (PBMCs, tumour and other tissues), cytokine analysis using the Luminex multiplex system, in vivo tumor models in mice, functional in vitro assays